Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FBRSL1 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
mRNA | FIZ1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | ZNF445 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
mRNA | PHIP | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | HNRNPA0 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | FAM117B | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | TFAP4 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | INTS7 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-09 |